Nottingham-based contract research organisation (CRO) Cellomatics Biosciences has today been recognised with one of the UK’s most prestigious business awards – the Queen’s Award for Enterprise for International Trade.
Cellomatics is one of 225 organisations nationally to be recognised with a prestigious Queen’s Award for Enterprise.
Employing 15 people, Cellomatics was founded in 2015 and specialises in the development of bespoke bioassays across numerous therapeutic areas including oncology, immuno-oncology, immunology, inflammation and respiratory.